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Background: Neural tube defects related to polygenic
disorders are the second most common birth defects in
the world, but no molecular biologic tests are available
to analyze the genes involved in the pathomechanism of
these disorders. We explored the use of routinely col-
lected amniotic fluid to characterize the differential
gene expression profiles of polygenic disorders.
Methods: We used oligonucleotide microarrays to ana-
lyze amniotic fluid samples obtained from pregnant
women carrying fetuses with neural tube defects diag-
nosed during ultrasound examination. The control sam-
ples were obtained from pregnant women who under-
went routine genetic amniocentesis because of
advanced maternal age (>35 years). We also investigated
specific folate-related genes because maternal pericon-
ceptional folic acid supplementation has been found to
have a protective effect with respect to neural tube
defects.
Results: Fetal mRNA from amniocytes was successfully
isolated, amplified, labeled, and hybridized to whole-
genome transcript arrays. We detected differential gene
expression profiles between cases and controls. High-
lighted genes such as SLA, LST1, and BENE might be
important in the development of neural tube defects.
None of the specific folate-related genes were in the top
100 associated transcripts.
Conclusions: This pilot study demonstrated that a rou-
tinely collected amount of amniotic fluid (as small as 6
mL) can provide sufficient RNA to successfully hybrid-
ize to expression arrays. Analysis of the differences in
fetal gene expressions might help us decipher the com-
plex genetic background of polygenic disorders.
© 2006 American Association for Clinical Chemistry
Neural tube defect (NTD)4, the second most common
birth defect in the world (1 in 1000 live births), can be
easily diagnosed prenatally with fetal sonography com-
bined with screening of maternal serum for increased
-fetoprotein concentration. Genetic analysis of this dis-
order is lacking, however, because genetic diagnostic
methods including invasive techniques such as genetic
amniocentesis, chorion villus sampling, and cordocentesis
and noninvasive techniques such as analysis of fetal cells
and cell-free fetal DNA in maternal blood focus on
monogenic disorders or chromosomal anomalies. We do
not know exactly how many genes are involved in the
polygenic disorders such as NTD, which has a multifac-
torial etiology (1 ), but their pathomechanism may be
elucidated by analysis of genome-wide fetal gene expres-
sion. Research on fetal gene expression has, in large part,
been limited to animal models and examination of tissues
from aborted human fetuses. Genetic amniocentesis can
be used as a routine technique in which analysis can be
performed on amniocytes, which typically require in vitro
expansion. Currently, cell-free fetal DNA and RNA in
amniotic fluid are also the focus of many research studies
(2 ).
There is great interest in risk-free alternatives to am-
niocentesis, particularly prenatal diagnostic techniques
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that use fetal cells isolated from maternal blood (3-5).
Because the low number of fetal cells found in most
maternal samples (4 ) make this technique unsuitable for
gene expression analysis, we used amniocytes from am-
niotic fluid samples, in which all of the cells are thought to
be of fetal origin.
Development of gene expression microarrays to ana-
lyze the presence and quantity of tens of thousands of
gene transcripts simultaneously is made possible by the
information from the Human Genome Project combined
with recent technologic advances (6 ) such as the increased
feature density of the HG-U133 Plus 2.0 Array (Af-
fymetrix Inc.), which enables measurement of transcrip-
tion over the entire human genome in a single hybridiza-
tion. More than 54 000 probe sets are used to analyze the
expression of 47 000 transcripts and variants, including
38 500 well-characterized human genes.
We investigated the use of fetal mRNA extracted from
amniocytes to detect the presence and quantity of fetal
gene transcripts in the hope of identifying gene expres-
sion differences related to the pathogenesis of NTD.
Materials and Methods
amniotic fluid collection
We obtained approval from the Semmelweis University
institutional review board to collect amniotic fluid sam-
ples for this study. After informed consent was obtained
from participants, we collected amniotic fluid samples by
amniocentesis and centrifuged the samples for 15 min at
600g. We immediately placed the cell pellets into 3 mL
RNAlater RNA Stabilization Reagent (Quiagen GmbH).
These samples were stored at 80 °C until the RNA
isolation occurred.
cases
We have had 7204 live births in our department in the last
2 years. During that time, we had 7 pregnant women
carrying fetuses with NTD, diagnosed during ultrasound
examination. We obtained samples of amniotic fluid (7–17
mL) from each of these patients. One woman had a fetus
with anencephaly and spina bifida in the lumbosacral
region (sample MV1, gestational age 13 weeks and 2
days), 1 woman had a fetus with spina bifida in the
lumbosacral region (MV2, gestational age 17 weeks and 1
day), 4 had fetuses with ventriculomegaly, “lemon-
shaped” head, and lack of closure of the neural tube in the
lumbosacral region (MV3, MV4, MV5, MV13, gestational
ages of 19 weeks 1 day, 18 weeks 4 days, 19 weeks 6 days,
and 19 weeks), and 1 had a fetus with ventriculomegaly
and lumbosacral spina bifida (MV14, gestational age 20
weeks 3 days).
controls
We obtained the control samples (identified as MV6,
MV7, MV8, MV11, MV12) from 10 pregnant women
who underwent routine genetic amniocentesis because
of advanced maternal age (35 years). The fetal gesta-
tional ages were 17 weeks 1 day to 19 weeks 5 days. For
each of these cases we obtained only 3 mL of amniotic
fluid for analysis because larger amounts were needed
for routine examinations. As a result, before RNA isola-
tion, we pooled control samples by forming pairs ran-
domly, because preliminary experiments (unpublished
data) showed that 5–7 mL of amniotic fluid from a healthy
singleton pregnancy was needed to acquire a sufficient
quality and quantity of mRNA for microarray analysis.
total rna isolation
We isolated total RNA with the RNeasy Mini Kit (Quia-
gen GmbH). The frozen stabilized cell fractions in RNA-
later were centrifuged for 10 min at 400g, and the cell
pellets were lysed and homogenized in a mixture of 300
L 2,3,4,6-tetra-O-acetyl-beta-d-glucopyranosyl isothio-
cyanate–containing lysis buffer and 3 L -mercaptoetha-
nol. The lysed samples were digested in proteinase K
solution at 55 °C for 10 min. After silica membrane
cleaning and DNase I treatment (to completely remove
genomic DNA), we eluted the total RNAs in 50 L
RNase-free water.
QC
We tested the quantity and quality of the isolated RNA
with the Agilent 2100 Bioanalyzer. The high-quality, in-
tact RNA samples that showed regular 18S and 28S
ribosomal RNA bend pattern during Bioanalyzer analysis
were used for microarray analysis.
labeled probe synthesis
Biotinylated cRNA probes were synthesized from 10 ng
total RNA and fragmented according to the Affymetrix
protocols using GeneChip Two-Cycle Target Labeling
and Control Reagents (https://www.affymetrix.com/
support/downloads/manuals/expression_s2_manual.pdf).
hybridization, washing, staining, and
scanning
We hybridized 10 g of each fragmented cRNA sample
into a preheated prewet GeneChip U133 Plus 2.0 (Af-
fymetrix) whole-genome transcript array at 45 °C for 16 h,
with rotation at 0.5g. The slides were washed and stained
with Fluidics Station 450 (Affymetrix) and antibody am-
plification staining method according to the manufactur-
er’s instructions (sandwich phycoerythrin staining, proto-
col EukGE-WS2v5). The fluorescent signals were detected
by a GeneChip Scanner 3000 (Affymetrix).
statistical analysis
Preprocessing and QC. Preprocessing was performed in the
R statistical environment (7 ). QC analyses of microarrays
were performed according to the recent suggestions of
“Expression Profiling: Best Practices for Data Generation
and Interpretation in Clinical Trials” (8 ). Scanned images
were inspected for artifacts, and percentage of present
calls (30%) and control of the RNA degradation were
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evaluated, and all cell-line measurements fulfilled the
minimal quality requirements. According to the recom-
mendations, we applied 2 different processing methods:
Microarray Analysis Suite, version 5.0 (www.affymetrix.
com), and robust multichip average analysis (9 ). MAS 5.0
applied calibration to an individual chip with excellent
specificity and good sensitivity. Robust multichip average
analysis applied cross-project normalization, which had
good specificity and excellent sensitivity (www.R-project.
org). Further data analysis and interpretation carried out
with both of these preprocessing methods yielded the best
comparison and calibration properties across all measure-
ments.
Feature selection. We arranged the complete dataset con-
sisting of 9 expression measurements into 2 classes ac-
cording to the diagnosis of the samples (see Results). To
obtain characteristic signal profiles with high predictive/
discriminative power, we applied the Prediction Analysis
for Microarrays (PAM) (10 ), which uses soft thresholding
to produce a shrunken centroid that allows the selection
of genes with high discriminative potential. With only 4
samples in the diseased group, however, the search for a
minimum number of genes with maximum predictive
accuracy was not promising, because we could distin-
guish the 2 different groups with a very short gene list.
Furthermore, the individual cross-validation led to zero
misclassification error with only the very first discrimi-
nating gene (graph not shown). Therefore we selected the
top 100 discriminating genes for each condition. The PAM
score is presented in Table 1 to show the relative signifi-
cance of the selected gene.5 Finally, the overlap of the 2
lists—based on the 2 different processing methods—was
further analyzed (Fig. 1). To control the false discovery
rate, we performed a significance analysis of the microar-
rays.
Additional analyses. We performed hierarchical clustering
with Genesis software (11 ) and used the mean linkage
of Euclidean distances to compute clustering dendro-
grams for both samples and genes. We performed anno-
tation with the Affymetrix Netaffx analysis center (http://
www.affymetrix.com/analysis/index.affx) and used the
2-tailed Student t-test to test the differential expression of
single selected genes. Statistical significance was set at
P 0.05.
validation of microarrays
Because of the limited sample size, all RNA had to be
used for the cRNA chips. Real-time quantitative reverse-
transcriptase PCR, which would have been the optimal
method, could not be performed. However, in 1 case, we
had enough material to perform a 2nd run to indepen-
dently process the same sample from the same preg-
nancy to validate the accuracy of the microarray mea-
surements. Using this sample, we performed an
independent hybridization to a 2nd HG-U133 Plus 2.0
Array. After hybridization, the corresponding transcripts
on the 2 slides representing the same sample were spotted
against each other.
5 Human genes: SLA, Src-like-adaptor; LST1, leukocyte-specific transcript
1; BENE, BENE protein; KRT24, keratin 24; C9orf3, chromosome 9 open reading
frame 3; KIAA0779, KIAA0779 protein; TMCC1, transmembrane and coiled-
coil domain family 1; ZNF292, zinc finger protein 292; LOC153222, adult retina
protein; CBEP4, cytoplasmic polyadenylation element binding protein4;
TIGD2, tigger transposable element derived 2; UBAP2, ubiquitin associated
protein 2; AVPI1, arginine vasopressin-induced 1; KIAA0669, the same as
TSC22D2; TSC22D2, TSC22 domain family, member 2; DHFR, dihydrofolate
reductase; MTR, 5-methoyltetrahydrofolate-homocysteine methyltransferase;
ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide; KA36, type I hair
keratin; KRT4, Keratin 4; KRT9, Keratin 9.
Table 1. Genes detected in both statistical processing methods as having substantially different expression states in
fetuses with NTD compared with controls.
Probe Set ID UniGene ID Gene Symbol Gene Title Fold Difference PAM score
220267_at Hs0.87383 KRT24 Keratin 24 18.09 1.35
203760_s_at Hs0.75367 SLA Src-like-adaptor 2.72 0.97
232270_at Hs0.15806 C9orf3 Chromosome 9 open reading frame 3 3.49 0.72
213351_s_at Hs0.362996 KIAA0779 is TMCC1 KIAA0779 protein is transmembrane and coiled-coil
domain family 1
1.98 0.71
214181_x_at Hs0.436066 LST1 Leukocyte specific transcript 1 3.30 0.64
243918_at 6.87 2.12
212368_at Hs0.448341 ZNF292 Zinc finger protein 292 2.58 0.73
225956_at Hs0.163725 LOC153222 Adult retina protein 4.21 0.64
224828_at Hs0.108159 CPEB4 Cytoplasmic polyadenylation element binding
protein 4
5.34 0.57
229983_at Hs0.58924 TIGD2 Tigger transposable element Derived 2 2.82 1.13
219192_at Hs0.14953 UBAP2 Ubiquitin associated protein 2 2.18 0.51
218631_at Hs0.23918 AVPI1 Arginine vasopressin-induced 1 2.97 0.70
204094_s_at Hs0.52526 KIAA0669 is TSC22D2 KIAA0669 gene product is TSC22 domain family,
member 2
4.10 1.17
209373_at Hs0.185055 BENE BENE protein 3.52 0.46
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analysis of expression of genes associated
with folic acid
Administration of folic acid decreases the risk of NTD.
Therefore, to find out whether genes in connection with
folic acid showed differential expression in NTD fetuses,
specific genes were investigated and compared with con-
trol samples.
Results
total rna isolation, labeled crna synthesis,
and hybridization to microarrays
The volumes of obtained amniotic fluid, amount of total
RNA eluted, QC results of the isolated RNA, quantities of
biotinylated cRNA after amplification, and present calls
on whole-genome transcript arrays are shown in Table 2.
We excluded samples MV3 and MV5 from further analy-
sis because the eluted total RNA was found to be not
intact. Nine of the remaining 10 samples (5 samples from
the NTD group and 5 control samples), were well hybrid-
ized to the arrays. In these cases, the percentage of present
calls was 30%. Data from MV14 were not used in the
analysis because, in this case, the percentage of present
calls was only 16%.
Oligonucleotide whole genomic microarray analyses of
amniotic fluid cell fractions were of good quality consid-
ering the background and noise, array sensitivity, present
Fig. 1. Overview of the applied statistical processing methods.
RMA, robust multichip average analysis; FDR, false discovery rate; SAM, significance analysis of microarrays.
Table 2. Quantities of total RNA, isolated and amplified from amniocytes, and percentage of present calls on microarrays.
Amniotic fluid
volume, mL
Total RNA
eluted, ng
Quality control
(Bioanalyzer)
Biotinylated cRNA after
amplification, g
Present calls
on microarray, %
Cases with NTD
MV1 7 105 Intact 62.04 39.3
MV2 17 88 Intact 51.58 37.8
MV3 16 84.6 Not intact
MV4 16 96 Intact 10 32.9
MV5 16 36 Not intact
MV13 17 62.4 Intact 83.98 37.2
MV14 16 35 Intact 29.85 16.3
Controls
MV6 6 60 Intact 85.05 41.4
MV7 6 72 Intact 44.8 38.1
MV8 6 95 Intact 77.96 41.4
MV11 6 89.3 Intact 54.25 38.4
MV12 6 70.5 Intact 45.28 37.3
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percentage (signal intensity), and GAPDH 3/5 ratio. The
mean (SD) background [67.5 (12.8)] and noise [3.82 (0.72)]
values were low. The mean (SD) of percentages (the
signals that were considered present according to the
Affymetrix software) was 38.2 (2.54)%. The mean (SD)
GAPDH3/5 ratio was 5.24 (2.31), only slightly 3. Be-
cause of the extra manipulations involved, higher 3/5
ratios in the 2-cycle method than the 1-cycle method were
not unusual. The 2-cycle T7 method was suitable for
appropriate linear amplification of small amniotic fluid
samples that contained only 10–20 ng total RNA.
gene expression differences, discriminative
genes
Before finding top genes that had substantial differences
in expression in the diseased and control groups, we
applied 2 different processing methods. All genes selected
in at least 1 statistical analysis, with annotation, are shown
in Supplemental Table 1 of the Data Supplement that
accompanies the online version of this article at http://
www.clinchem.org/content/vol52/issue11. To find vali-
dated discriminative genes, we used the overlap of the 2
lists based on the 2 different processing methods. A
hierarchical cluster image of the transcripts selected after
using both processing techniques (top discriminative
genes, depicted in Table 1) is presented in Fig. 2. In the
NTD group compared with the control group, the genes
KRT24, C9orf3, KIAA0779 (TMCC1), ZNF292, LOC153222,
CBEP4, TIGD2, UBPP2, AVPI1, KIAA0669 (TSC22D2), and
BENE showed decreased expression and the genes SLA
and LST1 showed increased expression.
A list of the genes associated with folic acid can be
found as Supplemental Table 2 in the online Data Supple-
ment. The genes DHFR, MTR, and ATIC showed in-
creased expression in the NTD group compared with the
control group (Table 3).
According to the Significance Analysis of Microarray,
all genes detected by PAM, listed in Table 1,were signif-
icant at a false discovery rate 8%. The Pearson correla-
tion for validating the accuracy of the microarray mea-
surements was 0.997. Furthermore, the presence of Y
chromosome probe sets in male samples but not in female
samples provided physiologic validation of our data.
public data access
All microarray data, including MAS 5.0 processed and
raw data, are accessible in the Gene Expression Ominbus
(www.ncbi.nlm.nih.gov/geo) using the accession number
GSE4182. The array information required for Minimum
Information about a Microarray Experiment compliance
can be accessed using the GEO platform ID GPL570.
Discussion
This in vivo study of whole-genome expression by oligo-
nucleotide microarray analysis of fetal mRNA isolated
from amniocytes demonstrates that global gene expres-
sion array analysis can be performed with an amniotic
fluid sample as small as 6 mL, allowing the examination
Fig. 2. Hierarchical cluster image of tran-
scripts selected after both processing tech-
niques (top discriminative genes, listed in
Table 1).
Up-regulated genes are marked with red, down-
regulated genes are marked with green. The NTD
and normal cases are indicated with “b” and “n” at
the end, respectively. Gene symbols or Affymetrix
IDs are indicated.
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of individual fetuses by analysis of routinely collected
amniotic fluid samples. Total RNA was successfully iso-
lated from amniotic fluid cells, amplified, labeled, and
hybridized to whole-genome transcript arrays. The mean
of the signals considered present according to the Af-
fymetrix software was as high as that observed in higher
volume samples such as surgical tissue samples or biopsy
specimens.
The majority of nucleated cells in amniocentesis fluids
are derivatives of fetal epidermal cells. Exfoliation of such
cells from the fetal epidermis has been directly observed.
The hypothesis of epithelial origin was supported by
results of immunofluorescent studies with antibodies
against epidermal keratins (12 ). Furthermore, Greene-
baum and colleagues (13 ) demonstrated the presence of
neuroepithelial cells in amniotic fluids in cases with open
NTDs. Tsai and colleagues (14 ) found that clonal amniotic
fluid–derived stem cells from 2nd trimester amniocente-
sis expressed characteristics of neural progenitor cells.
Therefore, amniotic fluid cells are good candidates for
examination of this malformation process. Because it is
not possible to obtain samples from the living human
fetus at the expected time of neural tube closure (the 26th
day after conception), we used amniotic fluid samples
from amniocentesis performed in the 2nd trimesters to
study the expression profiles of amniocytes.
At this time, it is not possible to discriminate between
causality and downstream effects in regard to the differ-
ences in gene expression profiles we observed for NTD
and control groups. The kidney, intestine, and skin are
probable sources of cells that produce keratins. Therefore
the observed decrease in keratin expression (KTR24 in the
discriminative genes, KA36, KRT4, KRT9, in the top 100
associated transcripts) may be attributable to the presence
of fewer keratin-producing cells in direct contact with the
amniotic fluid in NTD cases. We also found decreased
expression of adult retina protein that could be related to
the defect of the neural tube. Expression was lowest in the
anencephalic case (MV1); higher in the 2 cases with
ventriculomegaly, “lemon-shaped head”, and missing
closure of the neural tube in the lumbosacral region (MV4
and MV13). Expression was highest in the case of spina
bifida alone (MV2) but was still lower than the gene
expression in the controls. BENE, 243918_at, and TSC22D2
showed the same profile. TSC-22 protein was expressed in
astrocytes (15 ). In the NTD group, we saw decreased
expression of TSC22D2. We also found decreased expres-
sion of CPEB4. Cytoplasmic polyadenilation element
binding proteins are important in the hippocampus,
where these proteins are thought to regulate local protein
synthesis and synaptic plasticity (16 ).
The compartmentalization of cellular membranes into
microdomains or rafts is an important concept in cell
biology. Unlike most membranes, which are enriched in
phospholipids and packed in a disordered state, rafts
have a high glycosphingolipid and cholesterol content
and appear to be packed in a liquid-ordered structure. In
polarized epithelial cells, the segregation and transport of
apical proteins during biosynthetic transport was initially
explained by the recruitment of specific proteins into
glycolipid- and cholesterol-enriched membrane (GEM)
rafts. MAL is an integral membrane proteolipid protein
expressed in polarized epithelial cells, oligodendrocytes,
and T lymphocytes. The BENE gene is a member of the
MAL gene family, which was identified in the GEM
fraction of endothelial cells. So BENE protein is an essen-
tial component of the GEM raft machinery for apical
sorting of membrane proteins (17 ). BENE proteins could
build a connection with epithelial cell polarity genes
required for neural tube closure (18 ). This theory is
supported with our finding of decreased expression of
BENE gene in the NTD group compared with the control
group.
Another difference in the gene expression profiles of
cases and controls could be attributed to the pathomecha-
nism of the disease. Monocytic cells can be found (12 ) in
amniotic fluid cell cultures from NTD pregnancies. The
Src-like adaptor protein (SLAP) is a negative regulator of
T-cell antigen receptor signaling (19 ) and also regulates
B-cell antigen receptor concentrations and signal strength
during lymphocyte development (20 ). SLAP is a negative
regulator of signaling initiated by growth factors (21 ). In
the NTD group, we found increased expression in the SLA
gene and decreased expression in the EGFR gene.
The LST1 gene is expressed in leukocytes and dendritic
cells. The expression of LST1 was increased in autoim-
mune-induced inflammation and in response to stimula-
tion with inflammatory mediators and bacterial agents,
Table 3. Genes in connection with folic acid with substantially different expression states in NTD cases compared with
controls. All 3 genes showed a higher expression in the diseased group.
Gene Symbol P Value Fold Change Probe Set ID UniGene ID Gene Title
ATIC 0.041 1.58 208758_at Hs0.90280 5-Aminoimidazole-4-carboxamide ribonucleotide
formyltransferase/IMP cyclohydrolase
DHFR 0.075 1.59 202532_s_at Hs0.83765 Dihydrofolate reductase
0.022 5.18 202533_s_at Hs0.83765 Dihydrofolate reductase
0.030 1.52 202534_x_at Hs0.83765 Dihydrofolate reductase
0.049 1.62 48808_at Hs0.83765 Dihydrofolate reductase
MTR 0.034 1.43 203774_at Hs0.82283 5-Methyltetrahydrofolate-homocysteine
methyltransferase
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suggesting that LST1 may play a role in inflammatory and
infectious diseases (22 ). We found increased expression of
LST1 gene in samples from the NTD group.
Taken together, the findings of higher expression of
SLA and LST1 genes in NTD samples highlights the
immunological aspect of this polygenic disease. Hatta and
colleagues (23 ) found that a persistent viral infection
could cause infected epithelial cells to lose cellular polar-
ity, leading to cell transformation. Therefore, if we hy-
pothesize that these changes may be connected with a
viral infection, we can make a putative correlation with
the decreased expression of BENE protein as well. The
idea of a viral infection in the pathogenesis of NTD is not
new; significant differences with the control group for
anencephaly and spina bifida in relation to maternal viral
upper respiratory infections was reported (24 ), and a
sudden increase in the incidence of NTD was also found
in newborns whose 1st trimester coincided with an epi-
demic of dengue fever (25 ). Maternal hyperthermia or
maternal fever in the 1st trimester was also found to
increase the risk of NTD (26, 27). Such data must be
interpreted with caution at this stage, and further inves-
tigation is necessary.
Unquestionably, the most significant epidemiological
finding with respect to NTD is the protective effect of
maternal periconceptional folic acid supplementation. Re-
ports from countries that have implemented fortification
programs indicate that the population prevalence of NTD
has declined. All pregnant women involved in our study
were taking a prenatal multivitamin, which is routinely
advised in Hungary. It is not surprising that there has
been substantial interest in the relationship between genes
involved in folate-related metabolic pathways and NTDs
(28 ). Although the folate pathway has been explored
extensively, only the methylenetetrahydrofolate reductase
677CT variant has been found to have an association,
and only in an Irish population (29 ). Theories regarding
the relationship between NTD and variants of specific
folate-related genes are largely unproven at this time (28 ).
None of the folate-related genes we investigated (see
Table 2 in the online Data Supplement) were in the top
100 associated transcripts. Genes of dihydrofolate reduc-
tase (1st enzyme of folate metabolism), 5-methyltetrahydro-
folate-homocysteine methyltransferase (enzyme playing a
role in the methylation cycle), and 5-aminoimidazole-4-
carboxamide ribonucleotide formyltransferase (important
enzyme in purine nucleotide biosynthesis) enzymes
showed an increased expression in NTD cases compared
with controls, a finding that suggests a compensating
effect for the developed NTD. Although identification of
the relationship between folic acid and NTD is valuable,
the discovery of other risk factors is essential. Our data
showed that aspirant genes playing an important role in
the pathogenesis of NTD were not specific folate-related
genes.
We attempted to create a data warehouse for genes
involved in the pathomechanism of NTD. The major
difficulty of collecting cases is the low incidence of the
disease (1 in 1000 live births), although it is the second
most common birth defect in the world. Because of the
small sample size, data must be interpreted with caution
at this stage, and further investigation is necessary.
In conclusion, we found that the technique of RNA
extraction from amniocytes and hybridization to expres-
sion arrays could be used with routinely collected amni-
otic fluid samples. The observed differences in gene
expression in NTD suggest that this technology might be
useful for elucidating the complex genetic background of
polygenic disorders in the living human fetus.
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